Neuroscience & CNS
Part of Biotech - Drug Development
 BIIB | Biogen Inc. Common Stock | $32.5b | $222.94 | 0.0% | 56 |
 JAZZ | Jazz Pharmaceuticals, Inc. | $15.3b | $230.75 | 0.0% | 1.1K |
 NBIX | Neurocrine Biosciences Inc | $14.6b | $145.50 | 0.0% | 165 |
 AXSM | Axsome Therapeutics, Inc | $9.4b | $174.41 | 0.0% | N/A |
 CYTK | Cytokinetics Inc. | $9.1b | $61.96 | 0.0% | 2 |
 TGTX | TG Therapeutics, Inc. | $8.3b | $52.00 | 0.0% | N/A |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $8.3b | $277.50 | 0.0% | N/A |
 ALKS | Alkermes Inc. plc | $7.0b | $41.65 | 0.0% | N/A |
 PTCT | PTC Therapeutics, Inc. | $5.3b | $63.75 | 0.0% | 40 |
 DFTX | Definium Therapeutics, Inc. Common Shares | $5.0b | $35.40 | 0.0% | 61 |
 INDV | Indivior Pharmaceuticals, Inc. Common Stock | $4.2b | $36.32 | 0.0% | N/A |
 XENE | Xenon Pharmaceuticals Inc | $3.7b | $36.45 | 0.0% | 130 |
 AMLX | Amylyx Pharmaceuticals, Inc. Common Stock | $3.5b | $28.04 | 0.0% | 1 |
 ACAD | Acadia Pharmaceuticals Inc. | $3.4b | $19.77 | 0.0% | 12 |
 RGC | Regencell Bioscience Holdings Limited Ordinary Shares | $3.4b | $7.37 | 0.0% | 131 |
 DNLI | Denali Therapeutics Inc. Common Stock | $3.2b | $19.28 | 0.0% | 5 |
 ATAI | AtaiBeckley Inc. Common Stock | $2.7b | $7.33 | 0.0% | N/A |
 SUPN | Supernus Pharmaceuticals, Inc. | $2.5b | $43.19 | 0.0% | 3 |
 HRMY | Harmony Biosciences Holdings, Inc. Common Stock | $2.3b | $39.35 | 0.0% | N/A |
 BHVN | Biohaven Ltd. | $1.9b | $12.05 | 0.0% | 71 |
 STOK | Stoke Therapeutics, Inc. Common Stock | $1.7b | $24.50 | 0.0% | N/A |
 GHRS | GH Research PLC Ordinary Shares | $1.6b | $21.48 | 0.0% | N/A |
 RAPP | Rapport Therapeutics, Inc. Common Stock | $1.5b | $30.50 | 0.0% | 5 |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.5b | $4.58 | 0.0% | N/A |
 LBRX | LB Pharmaceuticals Inc Common Stock | $1.2b | $34.23 | 0.0% | N/A |
 ANRO | Alto Neuroscience Inc. | $1.0b | $23.49 | 0.0% | N/A |
 TBPH | Theravance Biopharma, Inc. | $0.9b | $17.05 | 0.0% | N/A |
 ALMS | Alumis Inc. Common Stock | $0.9b | $6.97 | 0.0% | 8 |
 HELP | Helus Pharma Inc. Common Stock | $0.9b | $10.74 | 0.0% | 483 |
 ANNX | Annexon, Inc. Common Stock | $0.8b | $4.07 | 0.0% | N/A |
 COLL | Collegium Pharmaceutical, Inc. Common Stock | $0.7b | $21.88 | 0.0% | N/A |
 AQST | Aquestive Therapeutics, Inc. Common Stock | $0.6b | $4.62 | 0.0% | N/A |
 MPLT | MapLight Therapeutics, Inc. Common Stock | $0.5b | $9.70 | 0.0% | 5 |
 DRUG | Bright Minds Biosciences Inc. Common Stock | $0.5b | $48.48 | 0.0% | N/A |
 CTNM | Contineum Therapeutics, Inc. Class A Common Stock | $493.6m | $12.68 | 0.0% | N/A |
 OVID | Ovid Therapeutics Inc. Common Stock | $464.8m | $2.39 | 0.0% | N/A |
 PRTA | Prothena Corporation plc Ordinary Shares | $429.2m | $8.03 | 0.0% | 25 |
 RLMD | Relmada Therapeutics, Inc. Common Stock | $384.0m | $3.16 | 0.0% | 31 |
 VNDA | Vanda Pharmaceuticals Inc. | $279.9m | $4.55 | 0.0% | 320 |
 IKT | Inhibikase Therapeutics, Inc. Common Stock | $279.1m | $1.98 | 0.0% | N/A |
 ACIU | AC Immune SA | $270.9m | $2.51 | 0.0% | N/A |
 ELDN | Eledon Pharmaceuticals, Inc. Common Stock | $202.3m | $2.46 | 0.0% | 33 |
 ALEC | Alector, Inc. Common Stock | $202.1m | $1.81 | 0.0% | 90.9K |
 ACOG | Alpha Cognition Inc. Common Stock | $198.2m | $9.07 | 0.0% | N/A |
 NGEN | NervGen Pharma Corp. Common stock | $191.4m | $1.79 | 0.0% | 5 |
 AVXL | Anavex Life Sciences | $168.7m | $1.64 | 0.0% | 131 |
 PEPG | PepGen Inc. Common Stock | $157.9m | $2.31 | 0.0% | N/A |
 NERV | Minerva Neurosciences, Inc | $156.6m | $3.43 | 0.0% | N/A |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $152.8m | $7.81 | 0.0% | 527 |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $151.0m | $2.48 | 0.0% | 550 |